Technology | October 20, 2009

ScottCare Introduces Fully-Customizable Color Holter Recorder


October 20, 2009 – ScottCare Corp. this week released the Chroma Holter monitor, which the company says is the industry’s first full-color Holter monitor that more effectively addresses the needs of both the patient and the clinician.

The device offers the OLED (organic light-emitting diode) display featuring bold colors and a backlit screen, making it easier for clinicians and patients to work the device. It has an audible and visual patient lead disconnect alarms and medication/activity reminders to promote patient compliance and ensure a complete and accurate recording.

The company said Chroma is a fully-customizable recorder interface and controllability from any computer, enabling greater flexibility. It also has a superior ECG baseline correction, ensuring the cleanest, most accurate data. Advanced pacer detection with adjustable sensitivity helps accommodate the latest pacemaker technology. The system has sample rates of 128, 256, 512, and 1,024 with 8-,10- and 12-bit resolution. It also records up to 21 days of continuous, three-channel ECG data for deeper insight into elusive ECG data.

Ensuring proper hookup, the device also features smart cable detection to help users, with a customizable color display of the appropriate placement of either five or seven leads. Automatic recorder set-up allows the clinician to download patient demographic data, through an HL7 interface, from a clinic or hospital information system directly into the recorder.

Promoting patient compliance, the user-friendly, color-coded digital diary eliminates paper diary transcription.

The Chroma recorder and configurator work seamlessly with ScottCare’s powerful HolterCare software analysis system.

Chroma has both FDA clearance and CE mark.

For more information: www.scottcare.com


Related Content

News | ECG

March 4, 2026 — HeartBeam, Inc. has announced a commercial partnership with ClearCardio. In addition to serving as ...

Home March 06, 2026
Home
News | ECG

March 3, 2026 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for treating cardiovascular and ...

Home March 04, 2026
Home
News | ECG

Feb. 10, 2026 – AccurKardia, a provider of ECG-based diagnostics technology, recently announced results from a new study ...

Home February 24, 2026
Home
News | ECG

Feb. 18, 2026 — Researchers at the Mount Sinai Kravis Children’s Heart Center led a multicenter effort to develop and ...

Home February 20, 2026
Home
News | ECG

Dec. 10, 2025 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to HeartBeam, Inc. for its 12 ...

Home February 16, 2026
Home
News | ECG

Jan. 8, 2026 — AccurKardia recently announced U.S. Food and Drug Administration (FDA) 510(k) clearance and the ...

Home January 15, 2026
Home
News | ECG

Jan. 13, 2026 — AliveCor has received U.S. Food and Drug Administration (FDA) clearance for the next generation of KAI ...

Home January 14, 2026
Home
News | ECG

Oct. 8, 2025 — Viz.ai recently launched Viz ACS, a new solution in the Viz Cardio Suite. Designed to unite the acute ...

Home October 09, 2025
Home
News | ECG

Aug. 14, 2025 — During HeartBeam, Inc.'s second quarter 2025 earnings conference call, the medical technology company ...

Home August 15, 2025
Home
News | ECG

July 24, 2025 — Royal Philips has announced a collaboration with Epic to integrate Philips’ suite of cardiac ambulatory ...

Home July 24, 2025
Home
Subscribe Now